-
Pfizer builds on Braftovi bowel cancer OK with survival data
05 Feb 2025 05:06 GMT
… review based on a single clinical trial.
The Braftovi regimen also became … $11.4 billion takeover of Array Biopharma in 2019 – was previously approved …
-
Pfizer Drug Hits Goals of Colorectal Cancer Study, Clearing Way to Seek Full FDA Approval
05 Feb 2025 00:49 GMT
… 2019 acquisition of its developer, Array Biopharma, in an $11.4 billion … other main goal of the clinical trial, named BREAKWATER. At the American …
-
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight
20 Sep 2024 17:00 GMT
… therapies @ Squamous Cell Carcinoma Clinical Trials Squamous Cell Carcinoma Therapeutics Assessment …
5.
Squamous Cell Carcinoma Clinical Trial Therapeutics
6.
Squamous Cell … Group Co., Ltd., Novartis, Array BioPharma, among others. Basal Cell Carcinoma …
-
Brain Metastasis from Breast Cancer Pipeline Analysis 2024 Clinical Trials, FDA, EMA, PMDA Approvals, Emerging Therapies
09 Jul 2024 16:54 GMT
… Myers Squibb, Bayer, Northwest Biotherapeutics, Array BioPharma, and others.
• Promising Brain … Metastasis from Breast Cancer in clinical trials @ Brain Metastasis from … Brain Metastasis from Breast Cancer Clinical Trials
Brain Metastasis from Breast …
-
Bladder Cancer Treatment Market 2032: FDA Approvals, Clinical Trials, Therapies and Companies by DelveInsight
09 Jul 2024 12:30 GMT
Bladder cancer companies are Pfizer, Celgene, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GSK, Sanofi, Roche, Novartis, Johnson & Johnson, Merck, more
ALBANY, NEW YORK, UNITED STATES, July 9, 2024 /EINPresswire.com/ -- DelveInsight's …
-
Global KRAS Inhibitors Market & Clinical Trials Future Market Outlook 2030: A $600 Million Market Opportunity by 2030 - ResearchAndMarkets.com
24 Jun 2024 12:47 GMT
… in Clinical Trials > 90 Drugs
Global KRAS Inhibitor Clinical Trials Insight …
9. Marketed KRAS Inhibitor Clinical Trials Insight by Country, Company … AnBogen Therapeutics
Applied Pharmaceutical Science
Array BioPharma (Pfizer)
Ascentage Pharma
…
-
Antibody-Drug Conjugates In Oncology Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Companies By Delveinsight
07 Jun 2024 12:27 GMT
… -drug conjugates in oncology clinical trials, with over 30 major … , Eucure Biopharma, PharmaEngine, Vernalis, Array BioPharma, Genentech, Boehringer Ingelheim, Sentinel Oncology … Antibody-drug Conjugates in Oncology Clinical Trial Therapeutics
6. Antibody-drug …
-
Brain Metastasis From Breast Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals, Emerging Therapies, And Growth Prospects
05 Jun 2024 01:03 GMT
… Squibb, Bayer, Northwest Biotherapeutics, Array BioPharma, and others.
Promising Brain Metastasis … Metastasis from Breast Cancer in clinical trials @ Brain Metastasis from … Brain Metastasis from Breast Cancer Clinical Trials
Brain Metastasis from Breast …
-
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 Jan 2025 18:00 GMT
… (BRAFTOVI and MEKTOVI, developed by Array Biopharma) for patients with unresectable or … is currently in Phase II clinical trial. CFT1946 is an investigational, orally … know more about BRAF inhibitor clinical trials, visit @ BRAF Inhibitor Treatment Drugs …
-
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain
21 Mar 2024 17:00 GMT
… ) -- PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight … inhibitors @ PI3K Inhibitors Clinical Trials PI3K Inhibitors Therapeutics … Eucure Biopharma, PharmaEngine, Vernalis, Array BioPharma, Genentech, Boehringer Ingelheim, Sentinel …
About
© 1995-2025